No increased risk of breast or gynecologic malignancies in women exposed to spironolactone for dermatological conditions: a retrospective cohort study

Published: 26 February 2024| Version 1 | DOI: 10.17632/f8k8gs7wyr.1
Contributors:
Rachel Hill,
, Bilal Shaikh, Shari Lipner

Description

Supplemental Methods

Files

Categories

Breast Cancer, Gynecological Cancer, Acne, Hair Loss

Licence